37 related articles for article (PubMed ID: 34736137)
1. Novel sulfonamide-indolinone hybrids targeting mitochondrial respiration of breast cancer cells.
Helmy SWA; Abdel-Aziz AK; Dokla EME; Ahmed TE; Hatem Y; Abdel Rahman EA; Sharaky M; Shahin MI; Elrazaz EZ; Serya RAT; Henary M; Ali SS; Abou El Ella DA
Eur J Med Chem; 2024 Mar; 268():116255. PubMed ID: 38401190
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a highly selective inhibitor of the Aurora kinases.
Ferguson FM; Doctor ZM; Chaikuad A; Sim T; Kim ND; Knapp S; Gray NS
Bioorg Med Chem Lett; 2017 Sep; 27(18):4405-4408. PubMed ID: 28818446
[TBL] [Abstract][Full Text] [Related]
3. (1S,2E,4S,7E,11E)-2,7,11-Cembratriene-4,6-diol semisynthetic analogs as novel c-Met inhibitors for the control of c-Met-dependent breast malignancies.
Ebrahim HY; Mohyeldin MM; Hailat MM; El Sayed KA
Bioorg Med Chem; 2016 Nov; 24(22):5748-5761. PubMed ID: 27681240
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antitumor activities of novel 3-(6-aminopyridin-3-yl)benzamide derivatives: Inducing cell cycle arrest and apoptosis via AURKB transcription inhibition.
Zhao X; Wang R; Zhang F; Luo F; Zhong T; Linghu A; Xiong L; Yang H; Fan Y
Bioorg Chem; 2024 Jul; 148():107450. PubMed ID: 38761704
[TBL] [Abstract][Full Text] [Related]
5. Marine-Inspired Bis-indoles Possessing Antiproliferative Activity against Breast Cancer; Design, Synthesis, and Biological Evaluation.
Eldehna WM; Hassan GS; Al-Rashood ST; Alkahtani HM; A Almehizia A; Al-Ansary GH
Mar Drugs; 2020 Apr; 18(4):. PubMed ID: 32252280
[TBL] [Abstract][Full Text] [Related]
6. Discovery and optimization of dihydropteridone derivatives as novel PLK1 and BRD4 dual inhibitor for the treatment of cancer.
Liu J; Huang J; Wang K; Li Y; Li C; Zhu Y; He X; Zhang Y; Zhao Y; Hu C; Xi Z; Tong M; Li Z; Gong P; Hou Y
Bioorg Med Chem; 2024 Mar; 101():117609. PubMed ID: 38364599
[TBL] [Abstract][Full Text] [Related]
7. Anti-cancer activity of carbamate derivatives of melampomagnolide B.
Janganati V; Penthala NR; Madadi NR; Chen Z; Crooks PA
Bioorg Med Chem Lett; 2014 Aug; 24(15):3499-502. PubMed ID: 24928404
[TBL] [Abstract][Full Text] [Related]
8. 2-(3-Bromophenyl)-8-fluoroquinazoline-4-carboxylic Acid as a Novel and Selective Aurora A Kinase Inhibitory Lead with Apoptosis Properties: Design, Synthesis, In Vitro and In Silico Biological Evaluation.
Elsherbeny MH; Ammar UM; Abdellattif MH; Abourehab MAS; Abdeen A; Ibrahim SF; Abdelrahaman D; Mady W; Roh EJ; Elkamhawy A
Life (Basel); 2022 Jun; 12(6):. PubMed ID: 35743907
[TBL] [Abstract][Full Text] [Related]
9. Discovery of a Novel Pseudo-Natural Product Aurora Kinase Inhibitor Chemotype through Morphological Profiling.
Wang L; Yilmaz F; Yildirim O; Schölermann B; Bag S; Greiner L; Pahl A; Sievers S; Scheel R; Strohmann C; Squire C; Foley DJ; Ziegler S; Grigalunas M; Waldmann H
Adv Sci (Weinh); 2024 Jun; 11(21):e2309202. PubMed ID: 38569218
[TBL] [Abstract][Full Text] [Related]
10. Lymphocyte antigen 6K signaling to aurora kinase promotes advancement of the cell cycle and the growth of cancer cells, which is inhibited by LY6K-NSC243928 interaction.
Selvanesan BC; Varghese S; Andrys-Olek J; Arriaza RH; Prakash R; Tiwari PB; Hupalo D; Gusev Y; Patel MN; Contente S; Sanda M; Uren A; Wilkerson MD; Dalgard CL; Shimizu LS; Chruszcz M; Borowski T; Upadhyay G
Cancer Lett; 2023 Apr; 558():216094. PubMed ID: 36805500
[TBL] [Abstract][Full Text] [Related]
11. The Many Colors of the AURORA: Trial Design Issues Worth Noting.
Camargo JF; Natori Y
Clin Infect Dis; 2024 Apr; ():. PubMed ID: 38571315
[No Abstract] [Full Text] [Related]
12. Healed plaque erosion as a cause of recurrent vasospastic angina: a case report.
Yamamoto T; Toshimitsu I; Ishida A
Eur Heart J Case Rep; 2021 Oct; 5(10):ytab349. PubMed ID: 34738054
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and anticancer activity of new benzensulfonamides incorporating s-triazines as cyclic linkers for inhibition of carbonic anhydrase IX.
Zain-Alabdeen AI; El-Moselhy TF; Sharafeldin N; Angeli A; Supuran CT; El-Hamamsy MH
Sci Rep; 2022 Oct; 12(1):16756. PubMed ID: 36202955
[TBL] [Abstract][Full Text] [Related]
14. Indolin-2-one derivatives as selective Aurora B kinase inhibitors targeting breast cancer.
Dokla EME; Abdel-Aziz AK; Milik SN; Mahmoud AH; Saadeldin MK; McPhillie MJ; Minucci S; Abouzid KAM
Bioorg Chem; 2021 Dec; 117():105451. PubMed ID: 34736137
[TBL] [Abstract][Full Text] [Related]
15. A thienopyrimidine derivative induces growth inhibition and apoptosis in human cancer cell lines via inhibiting Aurora B kinase activity.
Li J; Hu H; Lang Q; Zhang H; Huang Q; Wu Y; Yu L
Eur J Med Chem; 2013 Jul; 65():151-7. PubMed ID: 23707920
[TBL] [Abstract][Full Text] [Related]
16. Discovery and optimization of novel phenyldiazepine and pyridodiazepine based Aurora kinase inhibitors.
Tamizharasan N; Gajendran C; Kristam R; Sulochana SP; Sivanandhan D; Mullangi R; Mathivathanan L; Hallur G; Suresh P
Bioorg Chem; 2020 Jun; 99():103800. PubMed ID: 32283344
[TBL] [Abstract][Full Text] [Related]
17. Novel acylureidoindolin-2-one derivatives as dual Aurora B/FLT3 inhibitors for the treatment of acute myeloid leukemia.
Jagtap AD; Chang PT; Liu JR; Wang HC; Kondekar NB; Shen LJ; Tseng HW; Chen GS; Chern JW
Eur J Med Chem; 2014 Oct; 85():268-88. PubMed ID: 25089810
[TBL] [Abstract][Full Text] [Related]
18. 2-Anilinopyrimidine derivatives: Design, synthesis, in vitro anti-proliferative activity, EGFR and ARO inhibitory activity, cell cycle analysis and molecular docking study.
AboulWafa OM; Daabees HMG; Badawi WA
Bioorg Chem; 2020 Jun; 99():103798. PubMed ID: 32247112
[TBL] [Abstract][Full Text] [Related]
19. Identification and Characterization of Natural and Semisynthetic Quinones as Aurora Kinase Inhibitors.
Furqan M; Fayyaz A; Firdous F; Raza H; Bilal A; Saleem RSZ; Shahzad-Ul-Hussan S; Wang D; Youssef FS; Al Musayeib NM; Ashour ML; Hussain H; Faisal A
J Nat Prod; 2022 Jun; 85(6):1503-1513. PubMed ID: 35687347
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
